scispace - formally typeset
D

Dominique Gaillard

Researcher at French Institute of Health and Medical Research

Publications -  85
Citations -  4582

Dominique Gaillard is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Cystic fibrosis & Epithelium. The author has an hindex of 37, co-authored 85 publications receiving 4147 citations. Previous affiliations of Dominique Gaillard include University of Reims Champagne-Ardenne.

Papers
More filters
Journal ArticleDOI

Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus

Sébastien Jacquemont, +182 more
- 06 Oct 2011 - 
TL;DR: In this article, the reciprocal duplication is associated with being clinically underweight, which is the main sign of a series of heterogeneous clinical conditions including failure to thrive, feeding and eating disorder and/or anorexia nervosa.

Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus

Sébastien Jacquemont, +180 more
TL;DR: The reciprocal impact of these 16p11.2 copy-number variants indicates that severe obesity and being underweight could have mirror aetiologies, possibly through contrasting effects on energy balance.
Journal ArticleDOI

Embryonic stem cells generate airway epithelial tissue.

TL;DR: It is shown by RT-PCR and immunocytochemistry that murine ES cells are able to differentiate into nonciliated secretory Clara cells, and that type I collagen induces this commitment, and when cultured at the air-liquid interface, ES cells give rise to a fully differentiated airway epithelium.
Journal ArticleDOI

Selective Up-Regulation of Chemokine IL-8 Expression in Cystic Fibrosis Bronchial Gland Cells in Vivo and in Vitro

TL;DR: The selective up-regulation of bronchial submucosal gland IL-8 could represent a primary event that initiates early airway sub mucosal inflammation in CF patients, and is relevant to the pathogenesis of CF.
Journal Article

Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.

TL;DR: It is reported that a new thiazolidinedione compound, BRL 49653, exerts potent effects on the expression of genes encoding proteins involved in fatty acid metabolism in preadipose cells, similar to those already described for natural or nonmetabolizable fatty acids.